Tangningtongluo Tablet for People With Prediabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.

Also called NCT05126251

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05126251
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05126251. Randomized; triple masking; primary purpose treatment. Start 2021-12-13 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tangningtongluo Tablet for People With Prediabetes
Condition
Prediabetes
Intervention (Drug)
Tangningtongluo tablet
Intervention (Behavioral)
lifestyle intervention
Lead sponsor
Beijing University of Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct05126251
Content hash
36f317e96e798934459b5c54c254c39bb3bba56fa6433db6e441fd38f179f024